Skip to main content

Subsite Title

Publications and Digital Products

Cart

Store Navigation

Share Buttons

Page title

National Substance Use and Mental Health Services Survey (N-SUMHSS) 2022: Data on Substance Use and Mental Health Treatment Facilities

Main page content

Download only

The N-SUMHSS is a voluntary annual survey of all active substance use and mental health facilities in the United States, its territories, and D.C. The annual report presents findings on the key operational characteristics of substance use and mental health treatment facilities, use of pharmacotherapies, language assistance services, and suicide prevention assistance services.

Publication ID
PEP23-07-00-002
Publication Date
September 2023
Format

You May Also Be Interested In

National Substance Use and Mental Health Services Survey (N-SUMHSS), 2021: Data on Substance Use and Mental Health Treatment Facilities

The N‑SUMHSS is a voluntary annual survey of all active substance use and mental health facilities in the United States, its territories, and D.C. The annual report presents findings on the general profile of substance use and mental health facilities, use of pharmacotherapies/medications, language assistance provided, and suicide prevention services.

Coordinated Specialty Care for First Episode Psychosis: Costs and Financing Strategies

This report will include data on the cost of CSC programs; how it is financed; case studies of cost reimbursement methodologies; funding options; trends in costs and financing for CSCs; data evaluation of Medicaid and private insurance coverage and barriers.

Drug Abuse Warning Network: Findings from Drug-Related Emergency Department Visits, 2022

An analysis of the 2022 DAWN data presents: (1) nationally representative weighted estimates of all drug-related emergency department (ED) visits, (2) nationally representative weighted estimates of the top substances involved in drug-related ED visits, including rates by race and ethnicity; (3) nationally representative weighted estimates of opioid- related ED visits by type of opioid, (4) drugs involved in polysubstance ED visits, and (5) the identification of newly mentioned drugs in 2022.

Drug Abuse Warning Network: Findings from Drug-Related Emergency Department Visits, 2021

An analysis of final 2021 DAWN data presents: (1) nationally representative weighted estimates, including percent and unadjusted rates per 100,000, for all drug-related emergency department (ED) visits, (2) nationally representative weighted estimates for the top five drugs in drug-related ED visits, (3) the assessment of monthly trends and drugs involved in polysubstance ED visits in a subset of sentinel hospitals, and (4) the identification of drugs new to DAWN’s Drug Reference Vocabulary.

Preliminary Findings from Drug-Related Emergency Department Visits, 2021: Results from the Drug Abuse Warning Network

An analysis of 2021 preliminary data presents (1) nationally representative weighted estimates for the top five drugs in drug-related ED visits, (2) the assessment of monthly trends and drugs involved in polysubstance ED visits in a subset of sentinel hospitals, and (3) the identification of drugs new to DAWN’s Drug Reference Vocabulary.

Use of Medication-Assisted Treatment in Emergency Departments

This guide examines emerging and best practices for initiating medication-assisted treatment in emergency departments. It also reviews the existing literature and science of the topic, identifies gaps in knowledge, and discusses challenges of implementation.